Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple therapy in early active rheumatoid arthritis
2004-002006-30Phase 4Completed
- Sponsor
- North Glasgow University Hospitals NHS Trust
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methotrexate, hydroxychloroquine and 5-aminosalicylic acid + sulphasalazine in rheumatoid arthritis (RA), sponsored by North Glasgow University Hospitals NHS Trust. Primary endpoint: Mean change in DAS28. Started Feb 2005; status: completed.
02
Drugs
methotrexatehydroxychloroquine5-aminosalicylic acid + sulphasalazine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-002006-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002006-30.